Skip to main content
Clinical Trials/NCT04237662
NCT04237662UnknownNot Applicable

The Impact of Enamel Matrix Derivatives on Periodontal Healing in Diabetic Patients After Non-Surgical Periodontal Therapy

University of Pisa1 site in 1 country38 target enrollmentStarted: January 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
38
Locations
1
Primary Endpoint
Pocket probing depth (PPD)

Study Overview

Brief Summary

The aim of this study is to compare periodontal treatment with or without the adjunct of an enamel matrix derivative in terms of periodontal healing in diabetic patients.

Detailed Description

Patients with periodontitis will be randomly allocated to two groups. In both groups, periodontal root instrumentation will be performed. In the test group, an additional flapless application of enamel matrix derivatives will be granted for sites with pockets deeper than 5 mm.

Metabolic glucose control as measured through blood testing and local parameters of periodontal health will be measured at baseline and three months after treatment completion.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Masking Description

Opaque envelopes

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients diagnosed with diabetes mellitus type II and currently under treatment;
  • •No previous periodontal treatment in the last 6 months;
  • •Presence of Periodontitis (Clinical attachment loss of at least 3 mm in 2 or more non- adjacent teeth);
  • •Ability to understand the study procedures and comply with them through the length of the study.

Exclusion Criteria

  • •Pregnancy and breast feeding;
  • •Need for antibiotic treatment during periodontal therapy;
  • •Chronic infections;
  • •Systemic diseases;
  • •Patients who report current smoking over 20 cigarettes per day.

Arms & Interventions

Control Group

Active Comparator

Root Instrumentation

Periodontal treatment is delivered with ultrasonic instrumentation performed with fine tips. The approach chosen is the one- stage full-mouth ultrasonic debridement in which all the treatment of diseased sites is performed within one hour.

Intervention: Root Instrumentation (Procedure)

Test Group

Experimental

Root Instrumentation + Enamel Matrix Derivative Application

Periodontal treatment is delivered with ultrasonic instrumentation performed with fine tips. The approach chosen is the one- stage full-mouth ultrasonic debridement in which all the treatment of diseased sites is performed within one hour.

In this group, at the end of the instrumentation enamel matrix derivatives is placed in all sites with a periodontal pocket depth deeper than 5mm.

Intervention: Root Instrumentation (Procedure)

Test Group

Experimental

Root Instrumentation + Enamel Matrix Derivative Application

Periodontal treatment is delivered with ultrasonic instrumentation performed with fine tips. The approach chosen is the one- stage full-mouth ultrasonic debridement in which all the treatment of diseased sites is performed within one hour.

In this group, at the end of the instrumentation enamel matrix derivatives is placed in all sites with a periodontal pocket depth deeper than 5mm.

Intervention: Enamel Matrix Derivative application (Device)

Outcomes

Primary Outcomes

Pocket probing depth (PPD)

Time Frame: Measured at Baseline and 3 months after treatment

Changes in PPD, measured orally through clinical examination. Unit of measure: mm

Secondary Outcomes

  • Number of sites with Pocket probing depth deeper than 5mm(Measured at Baseline and 3 months after treatment)
  • Full-mouth plaque score (FMPS)(Measured at Baseline and 3 months after treatment)
  • Oxford Happiness Questionnaire (OHQ)(Measured at Baseline and 3 months after treatment)
  • Glycated Hemoglobin (HbA1c)(Measured at Baseline and 3 months after treatment)
  • Clinical attachment level (CAL)(Measured at Baseline and 3 months after treatment)
  • Percentage of bleeding sites which measured Pocket probing depth deeper than 5mm at baseline(Measured at Baseline and 3 months after treatment)
  • Oral Health Index Profile-14 (OHIP-14)(Measured at Baseline and 3 months after treatment)
  • High sensitivity C-Reactive Protein (hsCRP)(Measured at Baseline and 3 months after treatment)
  • Recession of the gingival margin (REC)(Measured at Baseline and 3 months after treatment)
  • Percentage of sites with Pocket probing depth deeper than 5mm(Measured at Baseline and 3 months after treatment)
  • Full-mouth bleeding score (FMBS)(Measured at Baseline and 3 months after treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Filippo Graziani, DDS MClinDent PhD

Full Professor

University of Pisa

Study Sites (1)

Loading locations...

Similar Trials